Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix A Committee Member, Consultant, and Staff Biographies Ann E. Kurth, Ph.D., C.N.M., M.P.H., F.A.A.N. (Chair), is the dean and Linda Koch Lorimer Professor of the Yale School of Nursing. Dr. Kurth is an elected member of the National Academy of Medicine and a member of the 2014â2018 U.S. Preventive Services Task Force, which sets screen- ing and primary care prevention guidelines for the United States. She is a member of The New York Academy of Medicine and of the Connecticut Academy of Science and Engineering. Dr. Kurth is the 2018â2020 chair of the Consortium of Universities for Global Health, the more than 185 university member academic global health network. An epidemiologist and clinically trained nurseâmidwife, Dr. Kurthâs research focuses on HIV/ reproductive health and global health system strengthening, particularly in the context of climate change (see www.planetaryhealthnow.org). Her work has been funded by the U.S. National Institutes of Health (NIH)âNational Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, National Institute of Mental Health, National Institute of Child Health and Developmentâas well as the Bill & Melinda Gates Foundation, Joint United Nations Programme on HIV/AIDS, U.S. Centers for Disease Control and Prevention (CDC), Human Resources Services Administration, and others, for studies conducted in the United States and internationally. Dr. Kurth has consulted for the National Institutes of Health, Gates Foun- dation, World Health Organization, United States Agency for International Development, and CDC, among others. Dr. Kurth has published more than 200 peer-reviewed articles, book chapters, and scholarly monographs and presented at hundreds of scientific conferences and invited talks. Dr. Kurth has received awards for her science and leadership including the Friends 251
252 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA of the National Institute of Nursing Research Award and the International Nurse Researcher Hall of Fame award from Sigma Theta Tau International, the global nursing honor society. She chairs the National Academies of Sci- ences, Engineering, and Medicineâs Board on Global Health. Till BÃ¤rnighausen, M.D., Sc.D., M.Sc., M.Sc., is Alexander von Humboldt University Professor at Heidelberg University, Germanyâs oldest university, and director of the Heidelberg Institute of Global Health in the Faculty of Medicine. He is also adjunct professor of global health at the Harvard T.H. Chan School of Public Health, faculty affiliate at the Harvard Center for Population and Development Studies, and senior faculty at the Wellcome Trustâs Africa Health Research Institute in KwaZulu-Natal, South Africa. Dr. BÃ¤rnighausenâs research focuses on developing and testing population health interventions that address large health care needs in poor countries, in particular for HIV and other chronic conditions such as diabetes and hypertension. He focuses on interventions that can be implemented in re- source-poor settings, such as community health worker initiatives and novel interventions in nurse-led primary care clinics. In 2015, Dr. BÃ¤rnighausen won the Alexander von Humboldt Professor Award, Germanyâs most highly endowed international prize for science. Dr. BÃ¤rnighausen is principal in- vestigator on several U.S. National Institutes of Health grants (including 5 R01s). His research is also funded by the Wellcome Trust; the Alexander von Humboldt Foundation; the European Commission; the German Federal Ministry of Science and Education; World Health Organization; World Bank; Joint United Nations Programme on HIV/AIDS; UNITAID; United States Agency for International Development; ANRS (French National Agency for Research on AIDS and Viral Hepatitis); Clinton Health Access Initiative; Gavi, the Vaccine Alliance; Elton John AIDS Foundation; Rush Foundation; and the International Initiative for Impact Evaluation (3ie). Dr. BÃ¤rnighausen is a medical specialist in family medicine and holds doctoral degrees in population and international health (Harvard University) and history of medicine (University of Heidelberg), as well as masterâs degrees in health systems management (London School of Hygiene & Tropical Medicine) and financial economics (SOAS University of London). He pre- viously worked as a physician in China, Germany, and South Africa; as a journalist in Berlin; and as a management consultant for McKinsey & Co. in Europe. Dr. BÃ¤rnighausen has published more than 400 peer-reviewed articles, including in Science, PNAS, Lancet, BMJ, and PLoS Medicine. His work has attracted more than 35,000 citations. His h-index is 77 and he is a Clarivate Analytics/Web of Science âHighly Cited Researcher.â Eran Bendavid, M.D., M.S., is an associate professor of medicine at Stan- ford University, and a faculty affiliate in the Division of Infectious Diseases,
APPENDIX A 253 the Department of Health Research and Policy, and the Woods Institute for the Environment. His work, broadly, involves studying the drivers of population health improvements, mostly in lower-resource contexts. He explores how decisions about foreign assistance for health are made, and how those decisions affect the health of those whom assistance aims to serve. Dr. Bendavid is also a disease modeler, and uses that skill to explore issues of resource allocation in low- and middle-income countries with cost-effectiveness analyses. His recent research projects include an impact evaluation of the U.S. assistance program for HIV in Africa, and an explo- ration of the association between drug prices, aid, and health outcomes in countries heavily affected by HIV. He received a B.A. in chemistry and philosophy from Dartmouth College and an M.D. from Harvard Medical School. His residency in internal medicine and fellowship in infectious dis- eases were completed at Stanford. Carla Castillo-Laborde, M.Sc., M.A., is an assistant professor at the Cen- tro de EpidemiologÃa y PolÃticas de Salud, Facultad de Medicina ClÃnica Alemana, at the Universidad del Desarrollo, Santiago. Previously, she was a researcher at the Department of Health Economics of the Ministry of Health, Chile, from 2005 to 2012, participating in various studies related to the establishment of health reform, among others associated with areas of health economics, such as financing of health systems and economic evaluations. From October 2012 to June 2014, she was analyst of method- ologies at the Department of Methodologies in the Ministry of Social De- velopment, participating in the development and update of methodologies for social evaluation of projects, particularly for projects associated with the health sector or health effects. From April 2014 to January 2016, Ms. Castillo-Laborde worked as technical advisor to the Ministry of Health, specifically on issues related to private health system financing reform, and from April 2016 to July 2018, she was technical advisor at the Social Poli- cies Coordination of the Ministry of Finance, on economic issues related to health. She has also been a professor of introductory courses in economics and introduction to microeconomics at the Pontificia Universidad CatÃ³lica de Chile from 2006 to 2008, and of economic evaluations in health at the Universidad de Chile (for the Magister InformÃ¡tica MÃ©dica) from 2012 to 2014, in addition to various courses related to health economics prepared by the Chilean Chapter of the International Society for Pharmacoeconomics and Outcomes Research since 2012. Elvin H. Geng, M.D., M.P.H., is a professor of medicine in the Division of Infectious Diseases in the Department of Medicine and Director of the Center for Dissemination and Implementation at the Institute for Public Health, both at Washington University in St. Louis. He earned M.D. and
254 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA M.P.H. degrees from Columbia University and subsequently completed postdoctoral training through the Aaron Diamond AIDS Institute at The Rockefeller University (posted to Kunming, China) as well as fellowship training in infectious diseases at the University of California in San Fran- cisco. Using the lens of implementation science, Dr. Geng conducts research to optimize the use of evidence-based interventions in the public health response to HIV. His work is carried out through collaborations in Kenya, Zambia, and Uganda, as well as in a safety net setting in the United States. His current activities make use of a range of observational, mixed methods, quasi-experimental, and experimental methods. His work is sponsored by the Bill & Melinda Gates Foundation and the National Institutes of Health. Dr. Geng serves in an advisory capacity for the World Health Organization, nongovernmental organizations, and professional organizations. He is an academic editor at PLOS Medicine, a member of the editorial board of JAIDS and the Journal of the International AIDS Society, and the editor for implementation science at Current HIV/AIDS Reports. Fastone M. Goma, Ph.D., M.B.Ch.B., M.Sc., is an associate professor of physiology and cardiovascular health at the University of Zambia School of Medicine. He is a medical doctor with a Ph.D. in cardiovascular science from the University of Leeds. He also studied international public health at the University of Alabama at Birmingham and tobacco dependency treatment at the University of Toronto. Dr. Goma is also appointed senior scholar at the World Health Organization Collaborating Centre for Health Workforce Planning and Research at the University of Dalhousie, Canada. Currently he is director for the Centre for Primary Care Research (CPCR), which has taken on health systems and noncommunicable diseases (NCDs) as the main areas of focus for research and policy influence. Dr. Goma con- tinues to actively participate in processes of formulating and implementing risk-reduction strategies for NCDs in Zambia and Africa. He is the found- ing president for the Zambia Heart and Stroke Foundation, and an active member of the African Heart Network and World Heart Federation. The CPCR is the secretariat for the Zambia Tobacco Control Campaign, a com- munity advocacy group, and the International Tobacco Control Evaluation Project. Other research interests include palliative care, knowledge transla- tion, and indigenous knowledge systems. He has been a keen advocate of competency/needs-based approaches to health workforce planning. Laura Hoemeke, Dr.P.H.,Â is a global health policy consultant, and has nearly 25 years of experience in global health, including field assignments in Benin, the Central African Republic, Senegal, and Rwanda, and short-term assignments throughout East, West, and Central Africa. Her areas of exper- tise include policy analysis and program design and management. She has
APPENDIX A 255 worked in family planning, maternal and child health, malaria prevention and control, and HIV/AIDS prevention and control, as well as health sys- tems strengthening and health governance. Dr. Hoemeke served as United States Agency for International Development (USAID) Beninâs family health technical advisor for 4 years. In early 2003, she joined IntraHealth Inter- national as regional director for West and Central Africa, based in Senegal. From 2005 through early 2010, Dr. Hoemeke was based in Rwanda as the director of IntraHealthâs successful USAID-funded Twubakane Decentral- ization and Health Program, which contributed to the countryâs impressive results, particularly in the areas of health-sector decentralization, family planning, and child health. In 2010, she joined IntraHealthâs headquarters leadership team and served as director of communications and advocacy then director of health policy and systems through November 2018. Dr. Hoemeke has authored several publications and has spoken and presented at numerous global health conferences and other events. She earned her doctorate in public health from the University of North Carolina at Chapel Hill Gillings School of Global Public Health in health policy and manage- ment. She has an M.P.H. from Johns Hopkins University and a B.S. in journalism from Northwestern University. Angelina Kakooza-Mwesige, M.B.Ch.B., M.Med., Ph.D., is a senior lec- turer and a pediatric neurologist in the Department of Pediatrics and Child Health, School of Medicine, Makerere University College of Health Sci- ences in Kampala, Uganda. Her major research interests are in the fields of neurology and infectious diseases, with considerable experience in the field of HIV/AIDS and neurodevelopmental disorders, particularly cerebral palsy, autism, and epilepsy. Her doctoral study was on cerebral palsy, which she defended in May 2016 as a joint degree from the Karolinska Institute, Sweden, and Makerere University, Uganda. For her postdoctoral fellow- ship, she will continue to pursue her research interests, which will be key to addressing how acquired infections of mothers during pregnancy may have impacts on their pregnancy, as well as the development of neurode- velopmental disorders in their children with a focus on the Zika virus. Her postdoctoral fellowship is funded by the DELTAS Africa Initiative grant #DEL-15-011 to THRiVE-2 (an independent funding scheme of the Afri- can Academy of Sciencesâ Alliance for Accelerating Excellence in Science in Africa that is supported by the New Partnership for Africaâs Development Planning and Coordinating Agency, with funding from the Wellcome Trust grant 107742/Z/15/Z and the UK government). Dr. Kakooza-Mwesige is also closely involved in training post- and undergraduate medical and para- medical students on neurological disorders in children and has more than 20 years of experience in medical practice in low-resource settings. She was elected as the 2017â2021 chair of the Commission for African Affairs of
256 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA the International League Against Epilepsy. She is a board member on the African Child Neurology Association; African Regional Committee of the International Brain Research Organization (IBRO-ARC); and the Women in World Neuroscience, a branch of IBRO. She has been instrumental in the founding of the East African Academy on Childhood Disability, where she is the current treasurer. Dr. Kakooza-Mwesige has served on a previ- ous committee for the outcome and impact evaluation of global HIV/AIDS programs implemented under the Lantos-Hyde Act of 2008 at the National Academies of Sciences, Engineering, and Medicine. Emmanuel B. K. Luyirika, M.B.Ch.B., B.P.A.(Hons), M.P.A., M.Fam.Med., is the executive director of the African Palliative Care Association (APCA). Dr. Luyirika joined APCA as the executive director in 2012. He holds a bachelor of medicine degree from Makerere University in Uganda, a mas- terâs degree in family medicine from the Medical University of Southern Africa, and a postgraduate honors degree and a master of public admin- istration from University of Stellenbosch. As part of the master in family medicine, he conducted research focusing on issues around HIV among school-going teenagers. As part of the masterâs degree in public admin- istration from the University of Stellenboschâs School of Public Manage- ment and Planning, his research focused on the national HIV/AIDS policy of South Africa. He also holds an HIV certificate from the University of Witwatersrand in South Africa. Dr. Luyirika started his career as a medical officer in rural Uganda at Kagando Hospital, near the Rwenzori Mountains on the border with the Democratic Republic of Congo. He later moved to South Africa, where he worked at the Donald Fraser Hospital in Lim- popo Province, after which he trained in family medicine at the Medical University of Southern Africa, where he was also appointed lecturer in the Department of Family Medicine. Apart from practicing medicine in a hospital setting in South Africa, Dr. Luyirika worked as a facilitator in the Rural Health Initiative of the South African Academy of Family Practice, where he trained multidisciplinary teams to care for HIV patients and to develop home care strategies and kits as well as community HIV preven- tion strategies. Returning to Uganda in 2002, Dr. Luyirika accepted the role of overseeing the health care program run by Mildmay International as clinical director, and after 3 years he became the overall center director; after another 3 years he became Mildmay Internationalâs country director. In these roles, he was actively involved in HIV prevention, care, treatment, education, and research and oversaw more than 20,000 patients in care. In his current role at APCA, he is involved in overseeing palliative care devel- opment both in Uganda and across Africa. Dr. Luyirikaâs vision for APCAâs work in Africa is to strengthen health systems by integrating palliative care using evidence-based models and for advocating for policy development
APPENDIX A 257 and change for palliative care across the continent. He also values knowl- edge and best practice sharing in the region to influence stakeholders to ensure the integration of palliative care into national health-sector plans using available resources. Dr. Luyirika has also authored and coauthored a number of publications related to palliative care and HIV. Mosa Moshabela, Ph.D., M.Sc., M.B.Ch.B., M.Fam.Med., Dip.HIV (SA), is currently an associate professor and the dean in the School of Nursing and Public Health, University of KwaZulu-Natal, South Africa. A qualified phy- sician in family medicine and primary health care, he works as a chief medi- cal specialist in rural health medicine, and a public health scientist in health services, systems, and policy in KwaZulu-Natal, South Africa, with the aim of improving access, quality, and equity in health care. Dr. Moshabela is also adjunct faculty and a Wellcome Trust research fellow at the Africa Health Research Institute, South Africa, where he collaborates with the London School of Hygiene and Tropical Medicine, and conducts research in several countries in sub-Saharan Africa. He was previously the regional health advi- sor for the Millennium Villages Project in West and Central Africa, based at the Millennium Development Goals Centre in Mali/Senegal, working with the Earth Institute at Columbia University. Prior to the Earth Institute, he worked for 5 years as a senior lecturer in the School of Public Health at the University of Witwatersrand, Johannesburg, where he was also the director of the Rural AIDS and Development Action Research Programme. Cur- rently, Dr. Moshabelaâs research portfolio seeks to design, implement, and evaluate complex interventions in public health care services and programs, in ways appropriate for resource-poor settings in sub-Saharan Africa. Denis Nash, Ph.D., M.P.H., is a distinguished professor of epidemiology at the City University of New Yorkâs (CUNYâs) School of Public Health and the founding executive director of CUNYâs Institute for Implementation Science in Population Health. He has more than 20 years of expertise in implementation science. His experience includes extensive domestic and international work in implementation science, comparative effectiveness research, and large-scale epidemiologic studies examining key outcomes among persons with HIV. Dr. Nash brings seasoned expertise in study de- sign and methodological approaches to large-scale, âreal-worldâ research projects. Prior to joining CUNY, Dr. Nash was an Epidemic Intelligence Ser- vice Officer and subsequently the director of HIV/AIDS surveillance, where he played a key role in the implementation of named reporting for HIV. He also worked at ICAP at Columbia University as the director of monitoring, evaluation, and researchâspearheading a multicountry initiative collect- ing routine medical records electronically. Dr. Nash has vast global health implementation and research experience. He has worked extensively on
258 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA large-scale initiatives and research projects in sub-Saharan Africa, including on the Guinea Worm Eradication Program in Nigeria, sentinel HIV surveil- lance in Botswana and Nigeria, and rapid expansion/scale-up of HIV/AIDS care and treatment under the Presidentâs Emergency Plan for AIDS Relief in Burundi, Cote dâIvoire, Ethiopia, Kenya, Lesotho, Mozambique, Nigeria, Rwanda, South Africa, Swaziland, Tanzania, Uganda, and Zambia. Dr. Nash currently leads the U.S. National Institutes of Health (NIH) funded Ie- DEA Central Africa regional collaboration (as one of the multiple principal investigators with Kathryn Anastos), which is an implementation science study that follows more than 50,000 persons enrolled in HIV care in five Central African countries (Burundi, Cameroon, the Democratic Republic of Congo, the Republic of the Congo, and Rwanda). He has recently begun research collaborations on noncommunicable diseases, which includes a household population health survey of four urban slums in Port au Prince, Haiti. Dr. Nash has published more than 150 scientific articles, and his research is primarily funded by NIH and the U.S. Centers for Disease Con- trol and Prevention. Dr. Nash also serves as a standing member on NIH study section review panels, and holds secondary faculty appointments in the Department of Epidemiology at Columbia Universityâs Mailman School of Public Health and in the Department of Epidemiology and Population Health at the Albert Einstein College of Medicine. Charles Ok Pannenborg, Ph.D., is a national of the Netherlands and re- cently retired from the World Bank, where he served as its chief health advisor/director and chief health scientist. Previously he lived and worked in Bangladesh, Congo, Ethiopia, Pakistan, and Tanzania. Dr. Pannenborg served on the boards of the Tropical Disease Research program, the Global Forum for Health Research, the Council on Health Research for Develop- ment, and more recently on the board of IntraHealth International and as an interim director at the Pan American Health Organization. He also served as an advisor to the World Bankâs higher education programs, and as chairman of the Netherlands Commission on Global Health Research, as well as the Royal Tropical Instituteâs Board on Health. In the past 40 years, he has been a global leader in several highly successful infectious disease programs, in the introduction of joint sectorwide health reform programs in Asia and Africa, and in reform of health and medical education worldwide. He holds degrees from the law and medical schools of the Universities of Groningen, of Amsterdam, and of Toronto. Dr. Pannenborg remains ac- tive as an advisor for health reform efforts in lower-, middle-, and higher- income countries, as well as global multilateral health organizations. Derek J. Sloan, Ph.D., M.B.Ch.B., is a senior clinical lecturer and consul- tant infectious diseases physician with a joint appointment at the University
APPENDIX A 259 of St. Andrews and NHS Fife. He has previously worked extensively in southern Africa. In 2004, he was worked as a clinician at PCEA Chogoria Hospital in Kenya and supported setup of an HIV clinic which provided comprehensive rollout of antiretroviral therapy for the first time in the district. From 2005 to 2006 he was senior medical officer and tuberculosis (TB) lead for Hlabisa subdistrict in KwaZulu-Natal, South Africa, where the dual burden of HIV and drug-resistant TB had become a public health crisis. Subsequently, he completed a Wellcome Trustâfunded Ph.D. fellow- ship at the University of Liverpool Institute of Global Health and Liverpool School of Tropical Medicine. His work there was on the clinical pharma- cology of TB treatment, and included 2.5 years of combined clinical and academic work in Blantyre, Malawi. During that time Dr. Sloan was also an honorary lecturer at the University of Malawi College of Medicine, and edited The Clinical Book, a practical pocket textbook of local management protocols for common adult medical conditions that still acts as a standard guide for medical students, clinical officers, and doctors across the country. In 2015, he spent 3 months in Sierra Leone working as clinical lead on the UK-Med Quality Monitoring Team, supporting the NHS contribution to the Ebola virus disease outbreak in West Africa. His ongoing research interests are targeted toward clinical therapeutics questions of global pub- lic health significance, particularly in the treatment of TB, HIV, and other infections. Sheila D. Tlou, Ph.D., R.N., F.A.A.N. (until May 2019), is the chair of the Global HIV Prevention Coalition. From 2010 to June 2017, she was the UNAIDS regional director for Eastern and Southern Africa. She was a minister of health of Botswana, a former professor of nursing at the Uni- versity of Botswana, and the director of the World Health Organization Collaborating Centre for Nursing and Midwifery Development in Primary Health Care for Anglophone Africa. She has conducted research and taught courses to nursing, premedical, and social science students on gender is- sues relating to HIV/AIDS, sexual and reproductive health and rights, and aging and older persons. She has played a key role in the development of national nursing and medical education curricula, working to broaden the scope of health sciences education in her home country of Botswana. Dr. Tlou has been involved in the AIDS response since 1985 and has worked to increase community awareness of HIV/AIDS in Botswana using youth groups, nongovernmental organizations, and grassroots womenâs organiza- tions. She was HIV/AIDS coordinator at the University of Botswana from 2002 to 2004 and facilitated the formation of the Students Against AIDS Society. During her term as minister of health, Dr. Tlou contributed to the improvement of global health care, especially for women and girls. She led a comprehensive HIV/AIDS prevention, treatment, care, and support pro-
260 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA gram in Botswana with achievements including: a rollout of antiretroviral drugs and prevention of mother-to-child transmission to near universal uptake; decreased transmission of HIV from mother-to-child from about 30 percent in 2003 to about 8 percent in 2008; and decreased maternal mortality due to AIDS from 34 percent to 9 percent. As chairperson of Southern African Development Community (SADC) and of the African Union Ministers of Health in 2005 to 2006, Dr. Tlou provided leadership in the adoption of the SADC Malaria Eradication Program, the SADC HIV/AIDS Plan of Action, and the Maputo Plan of Action on Sexual and Reproductive Health and Rights. Dr. Tlou also represented Eastern and Southern Africa in the board of the Global Fund to Fight AIDS, Tubercu- losis and Malaria. STUDY STAFF Susan F. E. Milner, Ph.D., M.P.H. (Study Director), is a senior program officer for the Board on Global Health with the National Academies of Sciences, Engineering, and Medicine. Prior to her work with the National Academies, she served as the deputy coordinator and senior strategic in- formation advisor for the Presidentâs Emergency Plan for AIDS Relief in Malawi. From 2010 to 2016, Dr. Milner worked abroad as a consultant focusing on monitoring and evaluation and policy issues. Her clients in- cluded the Elizabeth Glaser Pediatric AIDS Foundation, the U.S. Centers for Disease Control and Prevention and the World Health Organizationâs Stop Transmission of Polio Program, and the Liverpool School of Tropi- cal Medicine. She has lived and worked in five African countries, includ- ing the fragile states of South Sudan and Libya. Earlier in her career, Dr. Milner focused on domestic health care issues, working in the Maryland Department of Health and Mental Hygiene as a policy analyst for the stateâs Medicaid and S-CHIP programs and as the director of public af- fairs for Planned Parenthood of Metropolitan Washington. Dr. Milner was the recipient of a 2004â2005 Fulbright Lecturing Award in Global/Public Health in AsunciÃ³n, Paraguay. She graduated from Cornell University with an A.B. in history and holds an M.P.H. in health policy and management and a Ph.D. in health services research from the Johns Hopkins Bloomberg School of Public Health. Cecilia Mundaca Shah, M.D., Dr.P.H., is a senior program officer for the Board on Global Health with the National Academies of Sciences, Engineering, and Medicine. She is currently the director of the Forum on Microbial Threats. Prior to leading the forumâs work, she directed the Multi-Stakeholder Initiative for Creating a Global Health Risk Framework for the Future. She was the study director for the National Academiesâ
APPENDIX A 261 Board on the Health of Select Populations report Beyond Myalgic Encel- phalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. She also served as a postdoctoral fellow with the National Academiesâ Board on Global Health on the âOutcome and Impact Evaluation of Global HIV/ AIDS Programs Implemented Under the Lantos-Hyde Act of 2008.â Prior to joining the National Academies, Dr. Shah was employed as the head of the Surveillance Center of the Emerging Infections Program in the U.S. Naval Medical Research Unit 6 in Lima, Peru. In that role, she led the successful implementation of a technology-based disease surveillance system (Alerta) at sites across the nation and the initial phase of a project sponsored by the U.S. Southern Command to expand Alerta to five other countries in South America. Alerta is a partnership involving the Peruvian Navy and the U.S. Navy. Dr. Shah also led the collaborative syndromic surveillance pilot im- plementation in the Peruvian Ministry of Health. She was part of the Early Warning Outbreak Recognition System Working Group and participated in several studies, including a field visit to evaluate the performance of the system in Lao Peopleâs Democratic Republic. She obtained her M.D. from San Marcos University in Lima, Peru, and her M.P.H. and Dr.P.H. from the Uniformed Services University of the Health Sciences in Bethesda, Mary- land. Her dissertation work focused on developing a framework to guide the implementation of disease surveillance systems in developing countries. Dr. Shah completed a certificate in emerging infectious disease epidemiology at the University of Iowa. Katye M. Magee, M.P.A., is an associate program officer for the Board on Global Health with the National Academies of Sciences, Engineering, and Medicine. Previously, she has also worked on the Board on Health Care Ser- vices and the Board on Population Health and Public Health Practice. Prior to joining the National Academies, Ms. Magee completed her bachelorâs degree at Tulane University, where she studied public health and English. She completed her masterâs of public administration at The George Wash- ington University, with concentrations in health and social policy. Emma Fine is an associate program officer for the Board on Global Health with the National Academies of Sciences, Engineering, and Medicine. Pre- viously, she has also worked on the Board on Behavioral, Cognitive, and Sensory Sciences. Ms. Fine completed her bachelorâs degree at the Univer- sity of California, Berkeley, where she studied public health and public policy. Prior to joining the National Academies, she interned for the U.S. Department of Health and Human Services in the Office of the Assistant Secretary of Preparedness and Response where she contributed research to the National Health Security Strategy Implementation Plan. Ms. Fine plans to pursue a graduate degree in public health.
262 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA T. Anh Tran is a research associate at the National Academies of Sciences, Engineering, and Medicine. She also currently staffs the Global Roadmap for Health Longevity Initiative with the National Academy of Medicine and has previously worked with the Forum on Microbial Threats within the Board on Global Health. Prior to joining the National Academies, Ms. Tran interned and worked for governmental and nonprofit organizations, including the Office of Global Affairs in the U.S. Department of Health and Human Services, where she supported the Global Health Security Agenda launch, and the American Lung Association, where she reported on state air quality in the United States. Ms. Tran completed her B.S. in public health at The George Washington University. Zaria Fyffe is a senior program assistant for the Food and Nutrition Board with the National Academies of Sciences, Engineering, and Medicine where she works on two projects relating to scoping existing feeding recommenda- tions from birth to 24 months and a workshop on exploring new evidence in nutrition during pregnancy and lactation. Ms. Fyffe also currently staffs the Board on Global Health with the National Academies. As a recent graduate, she previously worked at MedStar National Rehabilitation Net- work as a physical therapy technician. Ms. Fyffe completed her B.S. in public health science at the University of Maryland, College Park. She has plans to pursue her M.D./M.P.H. Michelle Kvalsund, D.O., M.S., is a clinical neurophysiologist and neu- roepidemiologist with special interest in tropical neurology and global health. Her research focuses on intersections between nutrition, infectious disease, and neurologic health and disease in resource-limited settings. As an assistant professor of neurology and director of adult global neurology initiatives within the Michigan State University Department of Neurol- ogyâs International Neurologic and Psychiatric Epidemiology Program, Dr. Kvalsund spends 9 months annually in Lusaka, Zambia, where she is a principal investigator for the âResearch on Assessments of Vitamin B12 and Evaluation of Neuropathy Study.â In detailing preventable nutritional and toxico-nutritional neurologic morbidity in resource-limiting settings, her research has important potential public health and health policy implica- tions relating to food production and storage, nutritional supplementation, and national and HIV formulary guidelines in resource-limited settings. Dr. Kvalsund also holds an adjunct appointment as an honorary lecturer at the University of Zambia School of Medicine Department of Internal Medicine and participates in clinical educational activities with medical students and postgraduates, holds a weekly general neurology clinic, and conducts inpatient consultations at the University Teaching Hospital. She is also the
APPENDIX A 263 director of the electromyography division of the University Teaching Hos- pital electrodiagnostic laboratory. Julie A. Pavlin, M.D., Ph.D., M.P.H., is the director for the Board on Global Health with the National Academies of Sciences, Engineering, and Medicine. Prior to joining the National Academies, Dr. Pavlin was the research area director for emerging infectious diseases and antimicrobial resistance and deputy research area director for HIV at the Infectious Disease Clinical Research Program, part of the Uniformed Services Uni- versity of the Health Sciences; before that, she was the deputy director of the Armed Forces Health Surveillance Center. She is a retired Colonel in the U.S. Army and previous assignments included serving as the chief of the Global Emerging Infections Department at the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand, where she developed surveillance programs for infectious diseases in Asia; the chief of the Field Studies Department at the Walter Reed Army Institute of Research where she played a pivotal role in developing the Electronic Surveillance System for the Early Notification of Community-based Epidemics, the U.S. De- partment of Defense real-time surveillance system; as well as two tours in South Korea. Dr. Pavlin received her A.B. from Cornell University, her M.D. from Loyola University, her M.P.H. from Harvard University, and her Ph.D. in emerging infectious diseases at the Uniformed Services Uni- versity of the Health Sciences. CONSULTANTS Bridget B. Kelly, M.D., Ph.D., is a consultant specializing in strategy devel- opment, research and evaluation, policy analysis, stakeholder engagement, and meeting design and facilitation. She worked previously at the National Academies of Sciences, Engineering, and Medicine for 8 years leading a portfolio of projects that included early childhood development and educa- tion, mental health, chronic diseases, HIV, and evaluation science. Among other projects, she was the study director for the 2010 report Promoting Cardiovascular Health in the Developing World and the study co-director for the 2013 Evaluation of PEPFAR. In her last position at the National Academies she served as the interim director of the Board on Children, Youth, and Families. More recently she co-founded the nonprofit Bridging Health & Community, with the mission of helping the health sector work more effectively with communities. Originally trained in medicine and de- velopmental neurobiology, she received an M.D. and a Ph.D. from Duke University, and a B.A. from Williams College. She is also an experienced dancer, choreographer, and arts administrator.
264 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA EnCompass LLC Team Sarah Smith Lunsford, Ph.D. (Team Lead), is a senior evaluation specialist with EnCompass. For the past 7 years she has served as a senior advisor, research and evaluation, at the United States Agency for International Development-funded Applying Science to Strengthen and Improve Systems project and Healthcare Improvement (HCI) project. In this role, she sup- ported qualitative research and evaluation efforts on such areas as insti- tutionalization of improvement, adaptation of quality improvement (QI) methods for community-level services, and scale and spread of QI in the context of HCIâs quality improvement activities. She has a Ph.D. in medi- cal anthropology from the University of Queensland, Australia, where she examined local practices around dengue fever treatment, prevention, and control in Cambodia. She also holds an M.A. in international relations and Spanish from the University of St. Andrews, Scotland, and an M.P.H. from Tulane University. She has conducted research and evaluation activities for the Futures Group, Inc., and Educational Services, Inc. Simon Hiltebeitel, M.A., has experience creating and supporting moni- toring plans and systems for HIV/AIDS, maternal and newborn health, injection safety, gender, nutrition, community health, febrile illness, tuber- culosis, vulnerable children, and family planning projects in Africa, Latin America, and Asia. Mr. Hiltebeitel has worked on a number of evaluations in technical areas including maternal and newborn care, HIV/AIDS, vul- nerable children, and alcohol and tobacco control. He enjoys creating data visualizations and working with colleagues to clearly communicate project results. Mr. Hiltebeitel was a Peace Corps volunteer in Russia, working as an English teacher in primary and secondary schools. Mr. Hiltebeitel holds a masterâs degree in European and Eurasian studies from The George Wash- ington University, with a focus on international development. Kelsey Simmons, M.A., supports EnCompassâs technical assistance and evaluation work, including designing and implementing qualitative and quantitative evaluations of large international and domestic projects. She has lived and worked throughout sub-Saharan Africa researching, design- ing, and evaluating programs in HIV/AIDS, maternal and child health, ma- laria, and health systems strengthening. Ms. Simmons also has experience designing monitoring and evaluation frameworks for social enterprises that measure operational efficiency, as well as social impact. She holds an M.A. in international development studies with concentration in global health monitoring and evaluation from The George Washington University. She is fluent in English, and has working proficiency in French and limited work- ing proficiency in Bemba and Hebrew.
APPENDIX A 265 Amy Bhopal, M.P.H., is a special projects associate at EnCompass with more than 5 years of experience and key strengths in monitoring and evalu- ation (M&E), data analysis, research, and program management for both international and domestic projects. Ms. Bhopal has experience designing and implementing M&E frameworks that measure operational efficiency as well as social impact; developing robust data collection, monitoring, and reporting tools; and conducting qualitative and quantitative data analyses. She also has experience providing capacity building and technical assistance in M&E to field-based partners and multisectoral stakeholders. Her port- folio of work includes adolescent health, HIV/AIDS, maternal and child health, sexual and reproductive health, education, democracy and gover- nance, and youth-based entrepreneurship in Cuba, Malawi, South Africa, and Uganda. At EnCompass, Ms. Bhopal plays a key role in supporting the United States Agency for International Developmentâs Latin America and the Caribbean/Cuba Monitoring, Evaluation, and Learning Services project and various strategic initiatives for the chief executive officer. Ms. Bhopal holds a bachelor of science in molecular, cellular, and developmental biol- ogy from the University of California, Los Angeles, and a master of public health from the University of San Francisco. Rebecca K. Cathcart, M.P.H., P.M.P., is a research and evaluation expert with more than 15 years of progressive field experience in monitoring and evaluation, capacity building, program evaluation, operations research, and program management. She specializes in the fields of global health and international development, with a strong focus on strategic planning, report writing, facilitation, quality improvement, qualitative and quantitative re- search, data management/analysis, and program design and planning. She has worked in 18 countries in Africa, including considerable experience in Rwanda. She has worked with a variety of donors and stakeholders includ- ing the United States Agency for International Development, U.S. Centers for Disease Control and Prevention, U.S. Department of Defense, U.S. Department of State, Global Affairs Canada, Children Investment Fund Foundation, United Nations, ELMA Foundation, Nike Foundation, and World Bank. Ms. Cathcart holds an M.P.H. from the University of North Carolina at Chapel Hill, and is fluent in English and French. Sylvestre Musengimana, M.A., is a Rwanda-based evaluation consultant with Encompass. His consulting expertise includes performance assessment and analysis, capacity development and strengthening, project implemen- tation, and monitoring and evaluation. Mr. Musengimana has extensive experience in qualitative and quantitative research, community engagement, gender, youth empowerment, social and behavior change communication, and workshop and conference facilitation. He has contributed to various
266 EVALUATION OF PEPFARâS CONTRIBUTION TO RWANDA donor-supported project evaluations in Rwanda, including efforts for the World Bank; United States Agency for International Development; UK Department for International Development; European Union; United Na- tions Educational, Scientific and Cultural Organization; United Nations Childrenâs Fund; EKN (the Swedish Export Credit Agency); and Canadian Department of Foreign Affairs, Trade, and Development (formerly known as CIDA). Mr. Musengimana earned his B.A. in school psychology from the University of Rwanda in 2000 and his M.A. in educational management and administration from Kampala International University in 2011.